Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity

Advanced Drug Delivery Reviews

Volumn 32, Issue 1-2, 1998, Pages 45-60

  Moghimi, S M ^a,b   Patel, H M ^c  

^a Micro Tek Syst Consult Serv in D   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c Sandol   (United Kingdom)

Author keywords

Liposome; Liver; Macrophage; Opsonin; Opsono phagocytosis; Reticuloendothelial system; Spleen

Indexed keywords

BLOOD; CELLS; DRUG INTERACTIONS; PHARMACOKINETICS; PROTEINS;

LIPOSOMES; OPSONIN; RETICULOENDOTHELIAL SYSTEM;

CONTROLLED DRUG DELIVERY;

CALCIUM; LIPOSOME; OPSONIN; PHOSPHOLIPID;

DRUG CLEARANCE; DRUG DELIVERY SYSTEM; OPSONIZATION; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STABILITY; RETICULOENDOTHELIAL SYSTEM; REVIEW; SPLEEN CELL; TISSUE SPECIFICITY;

EID: 0032496713     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00131-2     Document Type: Review

References (101)

1. Black C.D.V., Gregoriadis G. Interaction of liposomes with blood plasma proteins. Biochem. Soc. Trans. 12:1976;342-344.
2. Richards R.L., Gewurz H., Seigel J., Alving C.R. Interaction of C-reactive protein and complement with liposomes. J. Immunol. 122:1979;1185-1189.
3. R.L. Juliano, G. Lin, The binding of human plasma proteins to cholesterol containing liposomes, in: B. Tom, H. Six (Eds.), Liposomes and Immunobiology, Elsevier, New York, 1980, pp. 49-66.
4. Tall A.R. Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma HDL in the rat. J. Lipid Res. 21:1980;354-363.
5. Rossi J.D., Wallace B.A. Binding of fibronectin to phospholipid vesicles. J. Biol. Chem. 258:1983;3327-3331.
6. Wurm H. B-2-Glycoprotein-I (apolipoprotein H) interaction with phospholipid vesicles. Int. J. Biochem. 16:1984;511-515.
7. Griep M.A., Fujikawa K., Nelsestuen G.L. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles. Biochemistry. 24:1985;4124-4130.
8. Bonté F., Juliano R.L. Interactions of liposomes with serum proteins. Chem. Phys. Lipids. 40:1986;359-372.
9. Tall A.R., Tabas I., Williams K.J. Lipoprotein-liposome interactions. Methods Enzymol. 128:1986;647-657.
10. Bonté F., Hsu M.J., Papp A., Wu K., Regen S.L., Juliano R.L. Interactions of polymerizable phosphatidylcholine vesicles with blood components: Relevance to biocompatibility. Biochim. Biophys. Acta. 900:1987;1-9.
11. Senior J. Fate and behaviour of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
12. Juliano R.L. Factors controlling the kinetics and tissue distribution of liposomes, microspheres, and emulsions. Adv. Drug Deliv. Rev. 2:1988;31-54.
13. Moghimi S.M., Patel H.M. Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett. 233:1988;143-147.
14. Chonn A., Semple S.C., Cullis P.R. Separation of large unilamellar liposomes from blood components by a spin column procedure: Towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim. Biophys. Acta. 1070:1991;215-222.
15. Chonn A., Cullis P.R., Devine D.V. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J. Immunol. 146:1991;4234-4241.
16. Chonn A., Semple S.C., Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267:1992;18759-18765.
17. Patel H.M. Serum opsonins and liposomes: Their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carrier Syst. 9:1992;39-90.
18. Devine D.V., Wong K., Serrano K., Chonn A., Cullis P.R. Liposome-complement interactions in rat serum: Implications for liposome survival studies. Biochim. Biophys. Acta. 1191:1994;43-51.
19. Chonn A., Semple S.C., Cullis P.R. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles. J. Biol. Chem. 270:1995;25845-25849.
20. Scherphof G., Roerdink F., Waite M., Parks J. Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipo-proteins. Biochim. Biophys. Acta. 542:1978;296-307.
21. Poznansky M., Juliano R.L. Biological approaches to the controlled delivery of drugs: A critical review. Pharmacol. Rev. 36:1984;277-336.
22. S.M. Moghimi, L. Illum, S.S. Davis, Organ-specific targeting of synthetic and natural drug carriers, in: B.R. Zetter (Ed.), Homing Mechanisms and Cellular Targeting, Adv. Mol. Cell Biol. 9 (1994) 263-282.
23. Sleyster E.C., Knook D.L. Relation between localization and function of rat liver Kupffer cells. Lab. Invest. 47:1982;484-490.
24. Te Koppele J.M., Thurman R.G. Phagocytosis of Kupffer cells predominates in pericentral regions of the liver lobule. Am. J. Physiol. 22:1990;G814-G821.
25. Spanjer H.H., Scherphof G.L. Targeting of lactosylceramide liposomes to hepatocytes in vivo. Biochim. Biophys. Acta. 734:1983;40-47.
26. Scherphof G.L., Morselt H., Allen T.M. Intrahepatic distribution of long-circulating liposomes containing poly(ethylene glycol) distearoyl phosphatidylethanolamine. J. Liposome Res. 4:1994;213-228.
27. Dan C., Wake K. Modes of endocytosis of latex particles in sinusoidal endothelial and Kupffer cells of normal and perfused rat liver. Exp. Cell Res. 158:1985;75-85.
28. Steffan A.M., Gendrault J.L., McCuskey R.S., McCuskey P.A., Kirn A. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology. 6:1986;830-836.
29. Moghimi S.M. Mechanisms of splenic clearance of blood cells and particles: Towards development of new splenotropic agents. Adv. Drug Deliv. Rev. 17:1995;103-115.
30. Moghimi S.M. Exploiting bone marrow microvascular structure for drug delivery and future therapies. Adv. Drug Deliv. Rev. 17:1995;61-73.
31. Hudson G., Yoffey J.M. Reticuloendothelial cells in the bone marrow of the guinea pig. J. Anat. 97:1963;409-416.
32. Hussain M.M., Mahley R.W., Boyles J.K., Lindquist P.A., Brecht W.J., Innerarity T.L. Chylomicron metabolism: Chylomicron uptake by bone marrow in different animal species. J. Biol. Chem. 264:1989;17931-17938.
33. Tavassoli M. Intravascular phagocytosis in the rabbit bone marrow: A possible fate of normal senescent red cells. Br. J. Haematol. 36:1977;323-326.
34. Absolom D. Opsonins and dysopsonins - An overview. Methods Enzymol. 132:1986;281-348.
35. Serra M.V., Mannu F., Matera A., Turrini F., Arese P. Enhanced IgG- and complement-independent phagocytosis of sulfatide-enriched human erythrocytes by human monocytes. FEBS Lett. 311:1992;67-70.
36. Ulrich F., Zilversmit D.B. Release from alveolar macrophages of an inhibitor of phagocytosis. Am. J. Physiol. 218:1970;1118-1127.
37. Ulrich F., Meier F. Inhibition of phagocytosis: Effects of normal rabbit serum on E. coli uptake by rabbit alveolar macrophages. J. Reticuloendothel. Soc. 14:1973;8-17.
38. Tyrrell D.A., Richardson V.J., Ryman B.E. The effect of serum protein fractions on liposome cell interactions in cultured cells and perfused rat liver. Biochim. Biophys. Acta. 497:1977;469-480.
39. Moghimi S.M., Patel H.M. Differential properties of organ-specific serum opsonins for liver and spleen macrophages. Biochim. Biophys. Acta. 984:1989;379-383.
40. Moghimi S.M., Patel H.M. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta. 984:1989;384-387.
41. Sciezka J.F., Maggiora L.L., Wright S.D., Cho M.J. Role of complement C3 and C5 in the phagocytosis by human neutrophils. Pharm. Res. 8:1991;65-69.
42. Moghimi S.M., Patel H.M. Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells. Biochim. Biophys. Acta. 1135:1992;269-274.
43. Funato K., Yoda R., Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim. Biophys. Acta. 1103:1992;198-204.
44. Moghimi S.M., Patel H.M. Serum factors that regulate phagocytosis of liposomes by Kupffer cells. Biochem. Soc. Trans. 21:1993;128S.
45. 1. Pharm. Res. 12:1995;1775-1780.
46. Liu D., Liu F., Song Y.K. Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim. Biophys. Acta. 1235:1995;140-146.
47. Harashima H., Komatsu S., Kojima S., Yanagi C., Morioka Y., Naito M., Kiwada H. Species difference in disposition of liposomes among mice, rats, and rabbits: Allometric relationship and species dependent hepatic uptake mechanism. Pharm. Res. 13:1996;1049-1054.
48. Moghimi S.M., Patel H.M. Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearing rats. Biochim. Biophys. Acta. 1285:1996;56-64.
49. Nagayasu A., Uchiyama K., Nishida T., Yamagiwa Y., Kawai Y., Kiwada H. Is control of distribution of liposomes between tumors and bone marrow possible? Biochim. Biophys. Acta. 1278:1996;29-34.
50. Oja C.D., Semple S.C., Chonn A., Cullis P.R. Influence of dose on liposome clearance: Critical role of blood proteins. Biochim. Biophys. Acta. 1281:1996;31-37.
51. Semple S.C., Chonn A., Cullis P.R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry. 35:1996;2521-2525.
52. Hu Q., Liu D. Co-existence of serum-dependent and serum-independent mechanism for liposome clearance and involvement of non-Kupffer cells in liposome uptake by mouse liver. Biochim. Biophys. Acta. 1284:1996;153-161.
53. Liu F., Liu D. Serum independent liposome uptake by mouse liver. Biochim. Biophys. Acta. 1278:1996;5-11.
54. 2-macroglobulin of rat serum in the phagocytosis of colloidal particles. Biochim. Biophys. Acta. 493:1977;37-54.
55. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171-199.
56. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: Studies with poly(ethylene glycol) coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
57. E. Sim (Ed.), Humoral Factors, IRL Press, Oxford, 1993.
58. Michalek M.T., Bremer E.G., Mold C. Effect of gangliosides on activation of the alternative pathway of human complement. J. Immunol. 140:1988;1581-1587.
59. Roerdink F., Wassef N.M., Richardson E.C., Alving C.R. Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement. Biochim. Biophys. Acta. 734:1983;33-39.
60. Wassef N.M., Roerdink F., Richardson E.C., Alving C.R. Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes. Proc. Natl. Acad. Sci. USA. 81:1984;2655-2659.
61. Wassef N.M., Matyas G.R., Alving C.R. Complement-dependent phagocytosis of liposomes by macrophages: Suppressive effects of 'stealth' lipids. Biochem. Biophys. Res. Commun. 176:1991;866-874.
62. Alving C.R., Wassef N.M. Complement-dependent phagocytosis of liposomes: Suppression by 'stealth' lipids. J. Liposome Res. 2:1992;383-395.
63. Alving C.R., Swartz G.M. Jr. Antibodies to cholesterol, cholesterol conjugates and liposomes: Implications for atherosclerosis and autoimmunity. CRC Crit. Rev. Immunol. 10:1991;441-453.
64. Strejan G.H., Essani K., Surlan D. Naturally occurring antibodies to liposomes. II. Specificity and electrophoretic pattern of rabbit antibodies reacting with sphingomyelin-containing liposomes. J. Immunol. 127:1981;160-165.
65. Alving C.R. Natural antibodies against phospholipids and liposomes in humans. Biochem. Soc. Trans. 12:1984;342-344.
66. Alving C.R., Swartz G.M. Jr., Wassef N.M. Naturally occurring autoantibodies to cholesterol in humans. Biochem. Soc. Trans. 17:1989;637-639.
67. Wassef N.M., Johnson S.H., Graeber G.M., Swartz G.M. Jr., Schultz C.L., Hailey J.R., Johnson A.J., Taylor D.G., Ridgway R.L., Alving C.R. Anaphylatoid reactions mediated by autoantibodies to cholesterol in miniature pigs. J. Immunol. 143:1989;2990-2995.
68. Okada N., Yasuda T., Tsumita T., Shinomiya H., Utsumi S., Okada H. Regulation of glycophorin of complement activation via the alternative pathway. Biochem. Biophys. Res. Commun. 108:1982;770-775.
69. Hostetter M.K., Krueger R.A., Schmelling D.J. The biochemistry of opsonization: Central role of the reactive thiolester of the third component of complement. J. Infect. Dis. 150:1984;653-661.
70. Wright S.D., Meyer B.C. Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes. J. Immunol. 136:1986;1759-1764.
71. Wright S.D., Silverstein S.C. Tumor-promoting phorbol esters stimulate C3b and C3b receptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156:1982;1149-1169.
72. Lo S.K., Detmers P.A., Levin S.M., Wright S.D. Transient adhesion of neutrophils to endothelium. J. Exp. Med. 167:1989;1779-1793.
73. Hinglais N., Kazatchkine M., Mandet C., Appay M.D., Bariety J. Human liver Kupffer cells express CR1, CR3 and CR4 complement receptors. Lab. Invest. 82:1988;640-651.
74. Myones B., Dalzell J., Hogg N., Ross G. Neutrophil and monocyte cell surface p150,95 has iC3b receptor (CR4) activity resembling CR3. J. Clin. Invest. 82:1988;640-651.
75. Robinson A.P., White T.M., Mason D.W. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 57:1986;239-247.
76. Maruiwa M., Mizoguchi A., Russell G.J., Narula N., Stronska M., Mizoguchi E., Rabb H., Arnaout M.A., Bhan A.K. Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages. J. Immunol. 150:1993;4019-4030.
77. Lepay D.A., Steinman R.M., Nathan C.F., Murray H.W., Cohen Z.A. Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. J. Exp. Med. 161:1985;1503-1512.
78. Lee S.H., Crocker P., Gordon S. Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium Yoelii blood-stage infection on macrophages in liver, spleen, and blood. J. Exp. Med. 163:1986;54-74.
79. Gabizon A., Papahajopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA. 85:1988;6949-6953.
80. 1 on liposome circulation time: Evidence supporting dysopsonin hypothesis. Biochim. Biophys. Acta. 1166:1993;105-114.
81. Reinish L.W., Bally M.B., Loughrey H.C., Cullis P. Interaction of liposomes and platelets. Thromb. Haemost. 60:1988;518-523.
82. Loughrey H.C., Bally M.B., Reinish L.W., Cullis P.R. The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement. Thromb. Haemost. 64:1990;172-176.
83. Czop J.K., Fearon D.T., Austen K.F. Membrane sialic acid on targeted particles modulated their phagocytosis by a trypsin-sensitive mechanism on human monocytes. Proc. Natl. Acad. Sci. USA. 75:1978;3831-3835.
84. Cornacoff J.B., Hebert L.A., Smead W.L., Van Aman M.E. Primate erythrocyte-immune complex-bearing mechanism. J. Clin. Invest. 71:1983;236-247.
85. Patel H.M., Tuzel N.S., Ryman B.E. Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochim. Biophys. Acta. 761:1983;142-151.
86. Roerdink F.H., Regts J., Handel T., Sullivan S.M., Baldeschwieler J.D., Scherphof G.L. Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen; a combined biochemical and γ-ray perturbed angular correlation study. Biochim. Biophys. Acta. 980:1989;234-240.
87. Senior J., Crawley J.C.W., Gregoriadis G. Tissue distribution of liposomes exhibiting long half-lives in the circulation after in vivo injection. Biochim. Biophys. Acta. 839:1985;1-8.
88. Dave J., Patel H.M. Differentiation in hepatic and splenic phagocytic activity during reticuloendothelial blockade with cholesterol-free and cholesterol-rich vesicles. Biochim. Biophys. Acta. 888:1986;184-190.
89. Moghimi S.M., Patel H.M. Calcium as a possible modulator of Kupffer cell phagocytic function by regulating liver-specific opsonic activity. Biochim. Biophys. Acta. 1028:1990;304-308.
90. S.M. Moghimi, H.M. Patel, Techniques to study the opsonic effect of serum on uptake of liposomes by phagocytic cells from various organs of the RES, in: G. Gregoriadis (Ed.), Liposome Technology, Vol. III, CRC Press, Boca Raton, 1993, pp. 43-57.
91. Moghimi S.M., Muir I.S., Illum L., Davis S.S., Kolb-Bachofen V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta. 1179:1993;157-165.
92. Derksen J.T.P., Baldeschwieler J.D., Scherphof G.L. In vivo stability of ester- and ether-linked phospholipid-containing liposomes as measured by perturbed angular correlation spectroscopy. Proc. Natl. Acad. Sci. USA. 85:1988;9768-9772.
93. Bisgaier C.L., Siebenkas M.V., Williams K.J. Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J. Biol. Chem. 264:1989;862-866.
94. Nicholas A.R., Jones M.N. The effect of blood on the uptake of liposomal lipid by perfused rat liver. Biochim. Biophys. Acta. 1074:1991;105-111.
95. Stossel T.P. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonins. J. Cell Biol. 58:1973;346-356.
96. Ryder K.W. Jr., Kaplan J.E., Saba T.M. Serum calcium and hepatic Kupffer cell phagocytosis. Proc. Soc. Exp. Biol. Med. 149:1975;163-167.
97. Gardner B. The relation between serum calcium and tumour metastases. Surg. Gynecol. Obstet. 128:1969;369-374.
98. Gislason T., Palmer M., Nou E. Serum calcium in bronchial carcinoma: A population-based study. Eur. J. Respir. Dis. 70:1987;8-13.
99. Haskell C.M., De Vita V.T., Canellos G.P. Hypercalcemia in chronic granulocytic leukemia. Cancer. 27:1971;872-880.
100. Saba T.M., Antikatzides T.G. Humoral mediated macrophage response during tumour growth. Br. J. Cancer. 32:1975;471-482.
101. Luostarinen L.T.M., Vorne M. Clinical significance of lung uptake in liver scanning. Nucl. Med. 25:1986;15-18.